Chapter
Promising Results for Fluvoxamine as COVID-19 Treatment
1:27:24 - 1:35:29 (08:05)
A recent study has shown that Fluvoxamine, an antidepressant previously approved by the FDA, can significantly reduce COVID-19-related deaths and hospitalizations if taken in the early stages of the disease. A scientist from Emory University recommends it be used for those at high risk who are unvaccinated or cannot receive monoclonal antibodies.
Clips
Emory University School of Medicine scientist describes fluvoxamine as a major victory for drug repurposing.
1:27:24 - 1:33:06 (05:42)
Summary
Emory University School of Medicine scientist describes fluvoxamine as a major victory for drug repurposing. The study shows approximately 90% reduction in COVID-19 related deaths among those who took it as directed in early stages of the disease, and suggests it should be adopted for those at a high risk of deterioration and unable to receive monoclonal antibodies or vaccination.
ChapterPromising Results for Fluvoxamine as COVID-19 Treatment
Episode#549: The Random Show — Biohacking, Tim’s COVID Experience, Holiday Gift Ideas, Favorite New Apps, Bad Science, Quarantine Delights, and a Small Dose of NFTs and DAOs
PodcastThe Tim Ferriss Show
Tim Ferriss talks about his experience with COVID-19 and the symptoms he experienced, including severe headache, muscle soreness, respiratory distress, and labored breathing.
1:33:06 - 1:34:33 (01:26)
Summary
Tim Ferriss talks about his experience with COVID-19 and the symptoms he experienced, including severe headache, muscle soreness, respiratory distress, and labored breathing. He also discusses the challenging process of tapering off SSRIs during his illness.
ChapterPromising Results for Fluvoxamine as COVID-19 Treatment
Episode#549: The Random Show — Biohacking, Tim’s COVID Experience, Holiday Gift Ideas, Favorite New Apps, Bad Science, Quarantine Delights, and a Small Dose of NFTs and DAOs
PodcastThe Tim Ferriss Show
The speaker shares their personal experience of tapering off SSRIs and the symptoms they experienced, including rapid heart rate and sweating profusely, and highlights the importance of consulting with a doctor before changing medication.
1:34:33 - 1:35:29 (00:56)
Summary
The speaker shares their personal experience of tapering off SSRIs and the symptoms they experienced, including rapid heart rate and sweating profusely, and highlights the importance of consulting with a doctor before changing medication.